Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.
Magnani CF, Myburgh R, Brunn S, Chambovey M, Ponzo M, Volta L, Manfredi F, Pellegrino C, Pascolo S, Miskey C, Sandoval-Villegas N, Ivics Z, Shizuru JA, Neri D, Manz MG. Magnani CF, et al. Among authors: neri d. Mol Ther Oncolytics. 2023 Aug 20;30:150. doi: 10.1016/j.omto.2023.08.002. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37654971 Free PMC article.
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.
Magnani CF, Myburgh R, Brunn S, Chambovey M, Ponzo M, Volta L, Manfredi F, Pellegrino C, Pascolo S, Miskey C, Ivics Z, Shizuru JA, Neri D, Manz MG. Magnani CF, et al. Among authors: neri d. Mol Ther Oncolytics. 2023 Jul 19;30:56-71. doi: 10.1016/j.omto.2023.07.003. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37583386 Free PMC article.
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice.
Carbone C, De Luca R, Puca E, Agostini A, Caggiano A, Priori L, Esposito A, Ascrizzi S, Piro G, Salvatore L, De Sanctis F, Ugel S, Corbo V, Neri D, Tortora G. Carbone C, et al. Among authors: neri d. J Exp Clin Cancer Res. 2025 Jan 7;44(1):7. doi: 10.1186/s13046-024-03238-x. J Exp Clin Cancer Res. 2025. PMID: 39773310 Free PMC article.
A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells.
Volta L, Myburgh R, Hofstetter M, Koch C, Kiefer JD, Gobbi C, Manfredi F, Zimmermann K, Kaufmann P, Fazio S, Pellegrino C, Russkamp NF, Villars D, Matasci M, Maurer M, Mueller J, Schneiter F, Büschl P, Harrer N, Mock J, Balabanov S, Nombela-Arrieta C, Schroeder T, Neri D, Manz MG. Volta L, et al. Among authors: neri d. Hemasphere. 2024 Nov 19;8(11):e70055. doi: 10.1002/hem3.70055. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39564539 Free PMC article.
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells.
Volta L, Myburgh R, Pellegrino C, Koch C, Maurer M, Manfredi F, Hofstetter M, Kaiser A, Schneiter F, Müller J, Buehler MM, De Luca R, Favalli N, Magnani CF, Schroeder T, Neri D, Manz MG. Volta L, et al. Among authors: neri d. Leukemia. 2024 Dec;38(12):2598-2613. doi: 10.1038/s41375-024-02409-1. Epub 2024 Sep 18. Leukemia. 2024. PMID: 39294295 Free PMC article.
679 results